Skip to Content

Proteoglycans GRC: Frontiers in Basic Translational Proteoglycan Research to Improve Human Health

The program of the 2022 Proteoglycans GRC entitled “Frontiers in Basic and Translational Proteoglycan Research to Improve Human Health” will highlight the latest findings in fundamental proteoglycan research addressing biosynthesis, catabolism and synthesis as well as advances in the technologies used to study proteoglycans and glycosaminoglycans. A major focus of the 2022 Proteoglycans GRC is to underscore proteoglycans as therapeutic tools and targets. Thus, recent advances from preclinical studies using animal models to clinical studies targeting proteoglycans for treatment of various human diseases (e.g. COVID-19) will lead to discussions among basic scientists and clinical researchers from academia, research institutes, and the pharmaceutical industry.

2022 Proteoglycans Conference GRC